SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2152967

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2152967

Pharmaceutical Excipients Market by Product (Organic, Inorganic), Functionality (Fillers & Diluents, Binders, Lubricants), Formulation (Oral, Parenteral), Functionality Application (Stabilizers)-Global Forecast to 2031

PUBLISHED:
PAGES: 654 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

List of Tables

The global pharmaceutical excipients market is projected to reach USD 15.99 billion by 2031 from USD 11.95 billion in 2026, at a CAGR of 6.0% during the forecast period. The expansion of the pharmaceutical excipients market has been driven primarily by surging demand for pharmaceutical products and generic medicines, and R&D investments in novel excipient development.

Scope of the Report
Years Considered for the Study2026-2031
Base Year2025
Forecast Period2026-2031
Units ConsideredValue (USD billion)
SegmentsBy Product, Functionality, Formulation, Functionality Application
Regions coveredNorth America, Europe, Asia Pacific, Latin America, the Middle East, and Africa

Additionally, partnerships & collaborations with pharmaceutical companies and increased emphasis on patient-centric formulations will provide lucrative market growth opportunities. However, regulatory stringency and steep development costs are predicted to restrict the market.

In 2025, the fillers & diluents functionality held the highest share in the pharmaceutical excipients market.

The pharmaceutical excipients market, segmented by functionality, includes binders, suspending and viscosity agents, fillers and diluents, flavoring agents and sweeteners, colorants, coating agents, lubricants and glidants, preservatives, disintegrants, emulsifying agents, and other specialized roles. Among these, fillers and diluents play a critical role, especially in the production of solid oral dosage forms like tablets and capsules. Their importance continues to grow with the rising demand for oral medications, which remain the most preferred route due to ease of administration and patient compliance. Fillers and diluents provide bulk to formulations containing small amounts of active pharmaceutical ingredients and help ensure accurate dosage and improved content uniformity. From a manufacturing perspective, they contribute significantly to formulation stability, ease of processing, and scalability in mass production. They simplify processes such as blending, tableting, and encapsulation while enhancing the mechanical strength of tablets. For patients, these excipients improve mouthfeel, taste, and handling, which are crucial factors for pediatric and geriatric populations. As drug formulations become more complex, the demand for high-performance, multifunctional fillers and diluents that support controlled release and bioavailability enhancement is also rising, presenting significant growth opportunities in this excipient category.

The oral formulations segment accounted for the highest share of the pharmaceutical excipients market in 2025.

The pharmaceutical excipients market is categorized based on formulation types into oral formulations, topical formulations, parenteral formulations, and other formulations. Among these, the oral formulations segment held the largest market share in 2025, reflecting its dominance as the most widely used and traditional drug delivery method. The convenience, cost-effectiveness, and high patient compliance associated with oral administration make it a preferred choice for patients and healthcare providers. This segment continues to expand due to the rising demand for tablets, capsules, and other solid oral dosage forms. Furthermore, the rapid growth of the biopharmaceutical and generics industries is playing a pivotal role in driving demand for high-quality excipients that enhance drug stability, solubility, and bioavailability in oral products. The increasing prevalence of chronic conditions requiring long-term medication and the trend toward self-administration of drugs also contribute to the growth of this segment. As a result, pharmaceutical companies are investing in innovative oral drug formulations, boosting the need for advanced excipients tailored to these needs.

Asia Pacific is expected to grow at the highest CAGR in the global pharmaceutical excipients market from 2026 to 2031.

The pharmaceutical excipients market in the Asia Pacific region is expected to grow robustly and register the highest CAGR among all regions during the forecast period. Several interrelated factors are driving this expansion. One of the key advantages is the region's cost-effective manufacturing capabilities, which make it an attractive hub for pharmaceutical production and outsourcing. Countries like India, China, and South Korea offer abundant raw material availability, skilled labor, and favorable government policies that support pharmaceutical R&D and export-oriented manufacturing. Additionally, the Asia Pacific region has relatively lenient regulatory frameworks compared to Western markets, which accelerates product development and time-to-market. The rapid rise in per capita income, growing awareness of health and wellness, and increased healthcare spending are further fueling demand for generic drugs and, by extension, pharmaceutical excipients. Moreover, a surge in lifestyle-related chronic diseases and expanding geriatric populations have led to greater demand for innovative drug formulations, including oral solids and topical applications. These trends create significant opportunities for local and global excipient manufacturers to expand operations, invest in infrastructure, and form strategic partnerships to meet the growing regional demand.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side-70% and Demand Side-30%
  • By Designation: Managers-45%, CXOs & Directors-30%, and Executives-25%
  • By Region: North America-40%, Europe-25%, the Asia Pacific-20%, Latin America-10%, and the Middle East & Africa-5%

List of Key Companies Profiled in the Report

Key players in the pharmaceutical excipients market include Roquette Freres (France), ADM (US), , Evonik Industries AG (Germany), BASF SE (Germany), Ashland Inc. (US), Kerry Group plc (Ireland), MERCK KGaA (Germany), Associated British Foods plc (UK), Wacker Chemie AG (Germany), Air Liquide (France), DOW (US), Berkshire Hathaway Inc. (US), Colorcon (US), DFE PHARMA (Germany), Actylis (US), Croda International Plc (UK), Gattefosse (France), JRS Pharma (Germany), and Shin-Etsu Chemical Co., Ltd. (Japan).

Research Coverage

This research report categorizes the pharmaceutical excipients market by Product [Organic (Oleochemicals, Carbohydrates, Petrochemicals, Proteins, and Other Organic Chemicals), Inorganic (Calcium Phosphate, Metal Oxides, Halites, Calcium Carbonate, Calcium Sulfate, Other Inorganic Chemicals), Other chemicals], by Functionality (Fillers & Diluents, Suspending & Viscosity Agents, Coating Agents, Binders, Flavoring Agents & Sweeteners, Disintegrants, Colorants, Lubricants & Glidants, Preservatives, Emulsifying Agents, and Other Functionalities), by formulation (Oral (Tablets, Capsules, Liquid Formulations and other oral formulations), Topical Formulations, Parenteral Formulations, and Other Formulations), by Functionality Application (Stabilizers, Taste Masking, Modified Release, Solubility & Bioavailability Enhancement and Other Functionality Applications), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa).

The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the pharmaceutical excipients market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. The report also covers new approvals/launches, collaborations, acquisitions, and recent developments associated with the pharmaceutical excipients market.

Reasons to Buy this Report

The report will help market leaders and new entrants by providing them with the closest approximations of the revenue numbers for the overall pharmaceutical excipients market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their businesses and devise suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

  • Analysis of key drivers (Surging demand for generic medications and pharmaceutical formulations, Increased R&D investments to develop novel excipients, A growing focus on patient-centric drug formulations, Strategic collaborations and partnerships with pharmaceutical firms), restraints (Strict and complex regulatory frameworks, High costs associated with excipient development and manufacturing), opportunities (Increasing interest in functional and multifunctional excipients, Technological advancements, particularly in nanotechnology, Expansion into emerging economies across Asia Pacific and Latin America), and Challenges (Ongoing concerns about excipient safety and quality standards, Limited availability and fluctuating costs of key raw materials).
  • Product Development/Innovation: Detailed insights on upcoming products, research and development activities, and new product approvals/launches in the Pharmaceutical Excipients market.
  • Market Development: Comprehensive information about lucrative markets; the report analyzes the market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the pharmaceutical excipients market.

Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players. A detailed analysis of the key industry players has been done to provide insights into their key strategies, product launches/ approvals, acquisitions, partnerships, agreements, collaborations, other recent developments, investment and funding activities, brand/product comparative analysis, and vendor valuation and financial metrics of the pharmaceutical excipients market.

Show more
Product Code: PH 3047

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 SEGMENTS CONSIDERED
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

  • 2.1 KEY INSIGHTS & MARKET HIGHLIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: INSIGHTS & STRATEGIC DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH
  • 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
  • 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET SNAPSHOT
  • 3.2 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION AND COUNTRY, 2025
  • 3.3 PHARMACEUTICAL EXCIPIENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Surging demand for generic medications and pharmaceutical formulations
      • 4.2.1.2 Increased R&D investments to develop novel excipients
      • 4.2.1.3 Growing focus on patient-centric drug formulations
      • 4.2.1.4 Collaborations and partnerships among pharmaceutical firms
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 Strict and complex regulatory frameworks
      • 4.2.2.2 High cost of excipient development and manufacturing
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 Increasing interest in functional and multifunctional excipients
      • 4.2.3.2 Technological advancements in nanotechnology
      • 4.2.3.3 Market opportunities in emerging economies
    • 4.2.4 CHALLENGES
      • 4.2.4.1 Ongoing concerns about excipient safety and quality standards
      • 4.2.4.2 Limited availability and fluctuating costs of key raw materials
  • 4.3 UNMET NEEDS & WHITE SPACES
  • 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
  • 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

  • 5.1 PORTER'S FIVE FORCES ANALYSIS
    • 5.1.1 BARGAINING POWER OF SUPPLIERS
    • 5.1.2 BARGAINING POWER OF BUYERS
    • 5.1.3 THREAT OF NEW ENTRANTS
    • 5.1.4 THREAT OF SUBSTITUTES
    • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.2 MACROECONOMIC OUTLOOK
    • 5.2.1 INTRODUCTION
    • 5.2.2 GDP TRENDS AND FORECAST
    • 5.2.3 TRENDS IN GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET
    • 5.2.4 TRENDS IN HEALTHCARE EXPENDITURE
  • 5.3 VALUE CHAIN ANALYSIS
  • 5.4 SUPPLY CHAIN ANALYSIS
  • 5.5 ECOSYSTEM ANALYSIS
  • 5.6 PRICING ANALYSIS
    • 5.6.1 INDICATIVE PRICING ANALYSIS, BY KEY PLAYER, 2025
    • 5.6.2 INDICATIVE PRICING ANALYSIS, BY REGION, 2025
  • 5.7 TRADE ANALYSIS
    • 5.7.1 TRADE DATA (HS CODE 290545)
      • 5.7.1.1 Import data for HS code 290545
      • 5.7.1.2 Export data for HS code 290545
    • 5.7.2 TRADE DATA (HS CODE 350510)
      • 5.7.2.1 Import data for HS code 350510
      • 5.7.2.2 Export data for HS code 350510
    • 5.7.3 TRADE DATA (HS CODE 290532)
      • 5.7.3.1 Import data for HS code 290532
      • 5.7.3.2 Export data for HS code 290532
    • 5.7.4 TRADE DATA (HS CODE 283650)
      • 5.7.4.1 Import data for HS code 283650
      • 5.7.4.2 Export data for HS code 283650
    • 5.7.5 TRADE DATA (HS CODE 250100)
      • 5.7.5.1 Import data for HS code 250100
      • 5.7.5.2 Export data for HS code 250100
    • 5.7.6 TRADE DATA (HS CODE 290543)
      • 5.7.6.1 Import data for HS code 290543
      • 5.7.6.2 Export data for HS code 290543
    • 5.7.7 TRADE DATA (HS CODE 3912)
      • 5.7.7.1 Import data for HS code 3912
      • 5.7.7.2 Export data for HS code 3912
  • 5.8 KEY CONFERENCES & EVENTS
  • 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.10 INVESTMENT/FUNDING ACTIVITY
  • 5.11 CASE STUDY ANALYSIS
    • 5.11.1 CASE STUDY 1: MOISTURE PROTECTION FOR MOISTURE-SENSITIVE TABLETS
    • 5.11.2 CASE STUDY 2: STABILIZATION OF MONOCLONAL ANTIBODY FORMULATIONS
  • 5.12 IMPACT OF 2025 US TARIFFS-PHARMACEUTICAL EXCIPIENTS MARKET
    • 5.12.1 INTRODUCTION
    • 5.12.2 KEY TARIFF RATES
    • 5.12.3 PRICE IMPACT ANALYSIS
    • 5.12.4 COMPARATIVE PRICING ON KEY EXCIPIENT PRE AND POST US 2025 TARIFFS
    • 5.12.5 IMPACT ON COUNTRIES/REGIONS
      • 5.12.5.1 North America
        • 5.12.5.1.1 US
      • 5.12.5.2 Europe
      • 5.12.5.3 Asia Pacific
    • 5.12.6 IMPACT ON END-USE INDUSTRIES

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

  • 6.1 TECHNOLOGY ANALYSIS
    • 6.1.1 KEY TECHNOLOGIES
      • 6.1.1.1 Co-processed excipient technology
      • 6.1.1.2 Nanotechnology-based excipients
    • 6.1.2 COMPLEMENTARY TECHNOLOGIES
      • 6.1.2.1 3D printing/additive manufacturing
      • 6.1.2.2 Process Analytical Technology (PAT)
    • 6.1.3 ADJACENT TECHNOLOGIES
      • 6.1.3.1 Artificial intelligence in formulation design
      • 6.1.3.2 Green chemistry/sustainability tech
  • 6.2 TECHNOLOGY/PRODUCT ROADMAP
  • 6.3 PATENT ANALYSIS
    • 6.3.1 TOP APPLICANTS/OWNERS (COMPANIES) FOR PHARMACEUTICAL EXCIPIENTS PATENTS, 2015-2025
  • 6.4 FUTURE APPLICATIONS
  • 6.5 IMPACT OF AI/GEN AI ON PHARMACEUTICAL EXCIPIENTS MARKET
    • 6.5.1 INTRODUCTION
    • 6.5.2 CASE STUDIES OF AI IMPLEMENTATION IN PHARMACEUTICAL EXCIPIENTS MARKET
    • 6.5.3 AI USE CASES
    • 6.5.4 KEY COMPANIES IMPLEMENTING AI
    • 6.5.5 FUTURE OF GENERATIVE AI IN PHARMACEUTICAL EXCIPIENT ECOSYSTEM
  • 6.6 SUCCESS STORIES AND REAL-WORLD APPLICATIONS

7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES

  • 7.1 REGULATORY LANDSCAPE
    • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 7.1.2 REGULATORY FRAMEWORK
      • 7.1.2.1 US
      • 7.1.2.2 Europe
      • 7.1.2.3 China
      • 7.1.2.4 India
      • 7.1.2.5 Brazil
    • 7.1.3 INDUSTRY STANDARDS
  • 7.2 SUSTAINABILITY INITIATIVES
  • 7.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

  • 8.1 DECISION-MAKING PROCESS
  • 8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
    • 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 8.2.2 KEY BUYING CRITERIA, BY END USER
  • 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
  • 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
  • 8.5 MARKET PROFITABILITY

9 PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT

  • 9.1 INTRODUCTION
  • 9.2 ORGANIC CHEMICALS
    • 9.2.1 OLEOCHEMICALS
      • 9.2.1.1 Fatty alcohols
        • 9.2.1.1.1 Wide usage of fatty alcohols as nonionic surfactants due to their amphipathic nature to drive market growth
      • 9.2.1.2 Mineral stearates
      • 9.2.1.3 Wide use of magnesium stearates as excipients in nutraceutical and pharmaceutical formulations to drive market growth
      • 9.2.1.4 Glycerin
        • 9.2.1.4.1 Extensive applications of glycerin to drive market growth
      • 9.2.1.5 Other oleochemicals
    • 9.2.2 CARBOHYDRATES
      • 9.2.2.1 Sugars
      • 9.2.2.2 Actual sugars
      • 9.2.2.3 Lactose
        • 9.2.2.3.1 Superior compressibility and widespread use in solid oral dosage forms to propel segment growth
      • 9.2.2.4 Sucrose
        • 9.2.2.4.1 Increasing usage of sucrose in pediatric, oral liquid, and lyophilized biologic formulations to drive growth
      • 9.2.2.5 Dextrose (D-Glucose)
        • 9.2.2.5.1 Growing use of dextrose in injectable and rehydration therapies to support growth
      • 9.2.2.6 Sugar alcohols
      • 9.2.2.7 Sorbitol
        • 9.2.2.7.1 Rising demand for sorbitol as stabilizer and sweetening agent in liquid and chewable formulations to fuel market
      • 9.2.2.8 Mannitol
        • 9.2.2.8.1 Expanding use of mannitol in solid dosage and lyophilized biologics due to its non-hygroscopic and stabilizing properties to aid growth
      • 9.2.2.9 Other sugar alcohols
      • 9.2.2.10 Artificial sweeteners
        • 9.2.2.10.1 Wide usage of aspartame as artificial sweetener to drive market growth
      • 9.2.2.11 Cellulose
      • 9.2.2.12 Microcrystalline cellulose
        • 9.2.2.12.1 Most widely used excipient in direct compression method for tablets to boost market
      • 9.2.2.13 Cellulose ethers
        • 9.2.2.13.1 Highly effective even at lower concentrations to boost demand for cellulose ethers
      • 9.2.2.14 CMC & croscarmellose sodium
        • 9.2.2.14.1 Multiple advantages of CMC and croscarmellose sodium to drive market growth
      • 9.2.2.15 Cellulose esters
        • 9.2.2.15.1 Delivery of drugs in cellular membranes and intracellular matrix to support market growth
      • 9.2.2.16 Starch
      • 9.2.2.17 Modified starch
        • 9.2.2.17.1 Growing use in sustained-release tablets due to its cold-water swelling and gel barrier formation capabilities to drive market growth
      • 9.2.2.18 Dried starch
        • 9.2.2.18.1 Strong binding and coating agent to boost adoption
      • 9.2.2.19 Converted starch
        • 9.2.2.19.1 Growing use of converted starch as molecular encapsulation agent to support market
    • 9.2.3 PETROCHEMICALS
      • 9.2.3.1 Glycols
        • 9.2.3.1.1 Availability of highly purified polyethylene glycol to enhance market demand
      • 9.2.3.2 Polyethylene glycol (PEG)
        • 9.2.3.2.1 Increasing adoption of PEG as versatile excipient in topical, oral, and parenteral formulations to boost market
      • 9.2.3.3 Propylene glycol (PG)
        • 9.2.3.3.1 Rising use in oral and injectable formulations for solvent, humectant, and preservative-enhancing functions to boost demand
      • 9.2.3.4 Povidones
        • 9.2.3.4.1 Rising demand for fast-dissolving tablets to propel growth
      • 9.2.3.5 Mineral hydrocarbons
        • 9.2.3.5.1 Growing preference for topical formulations in pain management to support demand for mineral hydrocarbons
      • 9.2.3.6 Petrolatum
        • 9.2.3.6.1 Occlusive and emollient properties of petrolatum to drive adoption
      • 9.2.3.7 Mineral waxes
        • 9.2.3.7.1 Utilization of mineral waxes in solid and semi-solid dosage forms for structure enhancement and controlled drug release to boost market
      • 9.2.3.8 Mineral oils
        • 9.2.3.8.1 Extensive use of mineral oils as solvents and emollients in topical, oral, and parenteral pharmaceutical applications to drive growth
      • 9.2.3.9 Acrylic polymers
        • 9.2.3.9.1 Wide use of acrylic polymers in controlled-release drug formulations to drive market growth
      • 9.2.3.10 Other petrochemical excipients
    • 9.2.4 PROTEINS
      • 9.2.4.1 Growing applications of proteins as carriers for microparticles and nanoparticles to drive market growth
    • 9.2.5 OTHER ORGANIC CHEMICALS
  • 9.3 INORGANIC CHEMICALS
    • 9.3.1 CALCIUM PHOSPHATE
      • 9.3.1.1 Chemical purity and low incompatibility with drugs to aid their high usage in pharmaceutical industry
    • 9.3.2 METAL OXIDES
      • 9.3.2.1 Availability of silicon oxides in hydrophobic, hydrophilic, and granulated forms to aid market growth
    • 9.3.3 HALITES
      • 9.3.3.1 Increased utilization of halites in vaccines and controlled-release formulations to drive market demand
    • 9.3.4 CALCIUM CARBONATE
      • 9.3.4.1 Properties such as short disintegration time and excellent mechanical strength to drive market
    • 9.3.5 CALCIUM SULFATE
      • 9.3.5.1 Advantages such as cost-effective, quality-enhancing diluent for solid dosage forms to boost demand
    • 9.3.6 OTHER INORGANIC CHEMICALS
  • 9.4 OTHER CHEMICALS

10 PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION

  • 10.1 INTRODUCTION
  • 10.2 ORAL FORMULATIONS
    • 10.2.1 TABLETS
      • 10.2.1.1 Wide usage of tablets to support market growth
    • 10.2.2 CAPSULES
      • 10.2.2.1 Hard-gelatin capsules
        • 10.2.2.1.1 Ease of manufacturing and versatility to drive growth of hard-gelatin capsules market
      • 10.2.2.2 Soft-gelatin capsules
        • 10.2.2.2.1 Stability concerns with highly water-soluble compounds and compounds susceptible to hydrolysis to restrict market growth
    • 10.2.3 LIQUID FORMULATIONS
      • 10.2.3.1 Liquid formulations require no dissolution time and boast faster absorption from stomach than tablets-key factors driving growth
    • 10.2.4 OTHER ORAL FORMULATIONS
  • 10.3 TOPICAL FORMULATIONS
    • 10.3.1 ADVANTAGES OF TOPICAL DRUG DELIVERY TO DRIVE DEMAND FOR EXCIPIENTS IN THIS SEGMENT
  • 10.4 PARENTERAL FORMULATIONS
    • 10.4.1 EMERGENCE OF NEW BIOLOGICAL MOLECULES TO INCREASE DEMAND FOR EXCIPIENTS
  • 10.5 OTHER FORMULATIONS

11 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY

  • 11.1 INTRODUCTION
  • 11.2 FILLERS & DILUENTS
    • 11.2.1 IMPROVED COHESION, DIRECT COMPRESSION, AND FLOW TO FINAL DOSE IN TABLETS TO BOOST MARKET DEMAND
  • 11.3 SUSPENDING & VISCOSITY AGENTS
    • 11.3.1 ADVANTAGES SUCH AS DRUG STABILITY AND TASTE MASKING TO BOOST MARKET GROWTH
  • 11.4 COATING AGENTS
    • 11.4.1 INCREASING USE OF SUSTAINED-RELEASE FORMULATIONS IN PHARMA INDUSTRY TO DRIVE MARKET GROWTH
  • 11.5 BINDERS
    • 11.5.1 FLUIDITY AND COMPRESSIBILITY ESSENTIAL FOR TABLET MANUFACTURING ASSOCIATED WITH BINDERS TO SUPPORT MARKET
  • 11.6 FLAVORING AGENTS & SWEETENERS
    • 11.6.1 ABILITY TO IMPROVE PALATABILITY OF DRUGS TO DRIVE DEMAND
  • 11.7 DISINTEGRANTS
    • 11.7.1 ABILITY TO CAUSE RAPID BREAK-UP OF SOLID DOSAGE FORMS TO BOOST ADOPTION
  • 11.8 COLORANTS
    • 11.8.1 GROWING USE IN HARD AND SOFT GELATIN CAPSULES, TABLETS, ORAL LIQUIDS, AND TOPICAL CREAMS TO FUEL GROWTH
  • 11.9 LUBRICANTS & GLIDANTS
    • 11.9.1 ABILITY TO IMPROVE FLOW PROPERTIES OF FORMULATIONS BY REDUCING INTERPARTICLE FRICTION AND COHESION TO DRIVE GROWTH
  • 11.10 PRESERVATIVES
    • 11.10.1 GROWING USE OF BENZYL ALCOHOL IN PHARMACEUTICAL AND NUTRACEUTICAL INDUSTRIES TO SUPPORT GROWTH
  • 11.11 EMULSIFYING AGENTS
    • 11.11.1 USE OF SOLUBILITY ENHANCEMENT EXCIPIENTS IN LIQUID DRUG FORMULATIONS TO INCREASE API BIOAVAILABILITY TO DRIVE DEMAND
  • 11.12 OTHER FUNCTIONALITIES

12 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION

  • 12.1 INTRODUCTION
  • 12.2 STABILIZERS
    • 12.2.1 ADVANTAGES SUCH AS IMPROVED DRUG SHELF LIFE AND FEWER MANUFACTURING DEFECTS TO BOOST DEMAND
  • 12.3 TASTE MASKING
    • 12.3.1 BENEFITS SUCH AS GREATER PATIENT COMPLIANCE AND ADHERENCE TO MEDICATION REGIMENS TO FUEL MARKET
  • 12.4 MODIFIED-RELEASE
    • 12.4.1 INCREASING USE OF MODIFIED-RELEASE FORMULATIONS IN PHARMA INDUSTRY TO DRIVE MARKET GROWTH
  • 12.5 SOLUBILITY & BIOAVAILABILITY ENHANCEMENT
    • 12.5.1 ESSENTIAL NATURE OF SOLUBILITY AND BIOAVAILABILITY FORMULATIONS FOR EFFECTIVE DRUG DELIVERY TO BOOST ADOPTION
  • 12.6 OTHER FUNCTIONALITY APPLICATIONS

13 PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION

  • 13.1 INTRODUCTION
  • 13.2 EUROPE
    • 13.2.1 GERMANY
      • 13.2.1.1 Germany accounted for largest share of European pharmaceutical excipients market in 2025
    • 13.2.2 UK
      • 13.2.2.1 Growing adoption of generics and development of novel multi-functional, co-processed excipients to drive market growth
    • 13.2.3 FRANCE
      • 13.2.3.1 Large geriatric population in country to support market growth
    • 13.2.4 ITALY
      • 13.2.4.1 Budgetary constraints and restricted healthcare spending to impede growth of Italian market
    • 13.2.5 SPAIN
      • 13.2.5.1 High consumption of biologics to support market growth
    • 13.2.6 REST OF EUROPE
  • 13.3 NORTH AMERICA
    • 13.3.1 US
      • 13.3.1.1 US to dominate North American market
    • 13.3.2 CANADA
      • 13.3.2.1 Strong growth of emerging markets and slowdown in new product approvals to hamper market growth in Canada
  • 13.4 ASIA PACIFIC
    • 13.4.1 CHINA
      • 13.4.1.1 Emphasis on generics and off-patent drugs to drive market in China
    • 13.4.2 JAPAN
      • 13.4.2.1 Rapid growth of Japan's geriatric population to greatly drive demand for pharmaceuticals
    • 13.4.3 INDIA
      • 13.4.3.1 Leading producer of generics to drive growth in India market
    • 13.4.4 SOUTH KOREA
      • 13.4.4.1 Presence of leading contract research and development organizations to propel market growth
    • 13.4.5 REST OF ASIA PACIFIC
  • 13.5 LATIN AMERICA
    • 13.5.1 BRAZIL
      • 13.5.1.1 Emerging opportunities for excipient manufacturers in Brazil to boost growth
    • 13.5.2 MEXICO
      • 13.5.2.1 Growing demand for affordable therapies and contract manufacturing to support growth
    • 13.5.3 REST OF LATIN AMERICA
  • 13.6 MIDDLE EAST
    • 13.6.1 GCC COUNTRIES
      • 13.6.1.1 healthcare infrastructure expansion and localization of drug manufacturing to drive excipients market in GCC Countries
    • 13.6.2 REST OF MIDDLE EAST
  • 13.7 AFRICA
    • 13.7.1 UNSATURATED MARKETS IN THE REGION HAVE DRAWN THE ATTENTION OF GLOBAL PLAYERS

14 COMPETITIVE LANDSCAPE

  • 14.1 INTRODUCTION
  • 14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL EXCIPIENTS MARKET, 2023-2026
  • 14.3 REVENUE ANALYSIS, 2023-2025
  • 14.4 MARKET SHARE ANALYSIS, 2025
  • 14.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
    • 14.5.1 STARS
    • 14.5.2 EMERGING LEADERS
    • 14.5.3 PERVASIVE PLAYERS
    • 14.5.4 PARTICIPANTS
    • 14.5.5 COMPETITIVE BENCHMARKING: KEY PLAYERS, 2025
      • 14.5.5.1 Company footprint
      • 14.5.5.2 Region footprint
      • 14.5.5.3 Product footprint
      • 14.5.5.4 Functionality footprint
      • 14.5.5.5 Functionality application footprint
  • 14.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
    • 14.6.1 PROGRESSIVE COMPANIES
    • 14.6.2 RESPONSIVE COMPANIES
    • 14.6.3 DYNAMIC COMPANIES
    • 14.6.4 STARTING BLOCKS
    • 14.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
      • 14.6.5.1 Detailed list of key startups/SMEs
      • 14.6.5.2 Competitive benchmarking of key startups/SMEs
  • 14.7 COMPANY VALUATION AND FINANCIAL METRICS
  • 14.8 BRAND/PRODUCT COMPARISON
  • 14.9 COMPETITIVE SCENARIO
    • 14.9.1 PRODUCT APPROVALS & LAUNCHES
    • 14.9.2 DEALS
    • 14.9.3 EXPANSIONS

15 COMPANY PROFILES

  • 15.1 KEY PLAYERS
    • 15.1.1 ROQUETTE FRERES
      • 15.1.1.1 Business overview
      • 15.1.1.2 Products offered
      • 15.1.1.3 Recent developments
        • 15.1.1.3.1 Product launches
        • 15.1.1.3.2 Deals
      • 15.1.1.4 MnM view
        • 15.1.1.4.1 Key strengths
        • 15.1.1.4.2 Strategic choices
        • 15.1.1.4.3 Weaknesses and competitive threats
    • 15.1.2 ARCHER-DANIELS-MIDLAND COMPANY
      • 15.1.2.1 Business overview
      • 15.1.2.2 Products offered
      • 15.1.2.3 Recent developments
        • 15.1.2.3.1 Deals
      • 15.1.2.4 MnM view
        • 15.1.2.4.1 Key strengths
        • 15.1.2.4.2 Strategic choices
        • 15.1.2.4.3 Weaknesses and competitive threats
    • 15.1.3 BASF SE
      • 15.1.3.1 Business overview
      • 15.1.3.2 Products offered
      • 15.1.3.3 Recent developments
        • 15.1.3.3.1 Deals
        • 15.1.3.3.2 Expansions
      • 15.1.3.4 MnM view
        • 15.1.3.4.1 Key strengths
        • 15.1.3.4.2 Strategic choices
        • 15.1.3.4.3 Weaknesses and competitive threats
    • 15.1.4 EVONIK INDUSTRIES AG
      • 15.1.4.1 Business overview
      • 15.1.4.2 Products offered
      • 15.1.4.3 Recent developments
        • 15.1.4.3.1 Expansions
      • 15.1.4.4 MnM view
        • 15.1.4.4.1 Key strengths
        • 15.1.4.4.2 Strategic choices
        • 15.1.4.4.3 Weaknesses and competitive threats
    • 15.1.5 ASHLAND INC.
      • 15.1.5.1 Business overview
      • 15.1.5.2 Products offered
      • 15.1.5.3 Recent developments
        • 15.1.5.3.1 Product launches and approvals
      • 15.1.5.4 MnM view
        • 15.1.5.4.1 Key strengths
        • 15.1.5.4.2 Strategic choices
        • 15.1.5.4.3 Weaknesses and competitive threats
    • 15.1.6 KERRY GROUP PLC
      • 15.1.6.1 Business overview
      • 15.1.6.2 Products offered
      • 15.1.6.3 Recent developments
        • 15.1.6.3.1 Deals
    • 15.1.7 MERCK KGAA
      • 15.1.7.1 Business overview
      • 15.1.7.2 Products offered
      • 15.1.7.3 Recent developments
        • 15.1.7.3.1 Deals
    • 15.1.8 ASSOCIATED BRITISH FOODS PLC
      • 15.1.8.1 Business overview
      • 15.1.8.2 Products offered
      • 15.1.8.3 Recent developments
        • 15.1.8.3.1 Deals
    • 15.1.9 WACKER CHEMIE AG
      • 15.1.9.1 Business overview
      • 15.1.9.2 Products offered
    • 15.1.10 AIR LIQUIDE S.A.
      • 15.1.10.1 Business overview
      • 15.1.10.2 Products offered
      • 15.1.10.3 Recent developments
        • 15.1.10.3.1 Product launches
    • 15.1.11 DOW INC.
      • 15.1.11.1 Business overview
      • 15.1.11.2 Products offered
    • 15.1.12 BERKSHIRE HATHAWAY INC. (LUBRIZOL CORPORATION)
      • 15.1.12.1 Business overview
      • 15.1.12.2 Products offered
    • 15.1.13 COLORCON, INC.
      • 15.1.13.1 Business overview
      • 15.1.13.2 Products offered
      • 15.1.13.3 Recent developments
        • 15.1.13.3.1 Product launches
        • 15.1.13.3.2 Deals
        • 15.1.13.3.3 Expansions
    • 15.1.14 DFE PHARMA GMBH & CO. KG
      • 15.1.14.1 Business overview
      • 15.1.14.2 Products offered
    • 15.1.15 ACTYLIS
      • 15.1.15.1 Business overview
      • 15.1.15.2 Products offered
      • 15.1.15.3 Recent developments
        • 15.1.15.3.1 Deals
    • 15.1.16 CRODA INTERNATIONAL PLC
      • 15.1.16.1 Business overview
      • 15.1.16.2 Products offered
      • 15.1.16.3 Recent developments
        • 15.1.16.3.1 Deals
        • 15.1.16.3.2 Expansions
    • 15.1.17 GATTEFOSSE SAS
      • 15.1.17.1 Business overview
      • 15.1.17.2 Products offered
    • 15.1.18 J. RETTENMAIER & SOHNE GMBH + CO KG
      • 15.1.18.1 Business overview
      • 15.1.18.2 Products offered
    • 15.1.19 SHIN-ETSU CHEMICAL CO., LTD.
      • 15.1.19.1 Business overview
      • 15.1.19.2 Products offered
      • 15.1.19.3 Recent developments
        • 15.1.19.3.1 Deals
        • 15.1.19.3.2 Expansions
  • 15.2 OTHER PLAYERS
    • 15.2.1 INNOPHOS HOLDINGS, INC.
    • 15.2.2 MEGGLE GMBH & CO. KG
    • 15.2.3 FUJI CHEMICAL INDUSTRIES CO., LTD.
    • 15.2.4 COREL PHARMA CHEM PVT. LTD.
    • 15.2.5 BIOGRUND GMBH
    • 15.2.6 NITIKA PHARMACEUTICAL SPECIALTIES PVT. LTD.
    • 15.2.7 R.T. VANDERBILT HOLDING COMPANY, INC.
    • 15.2.8 BENEO GMBH
    • 15.2.9 SIGACHI INDUSTRIES LIMITED
    • 15.2.10 JH NANHANG LIFE SCIENCES CO., LTD.

16 RESEARCH METHODOLOGY

  • 16.1 RESEARCH DATA
    • 16.1.1 SECONDARY DATA
      • 16.1.1.1 Objectives of secondary research
      • 16.1.1.2 Key data from secondary sources
    • 16.1.2 PRIMARY DATA
      • 16.1.2.1 Breakdown of primaries (supply- and demand-side participants)
      • 16.1.2.2 Key objective of primary research
  • 16.2 MARKET ESTIMATION
    • 16.2.1 GLOBAL MARKET ESTIMATION
      • 16.2.1.1 Company revenue analysis (bottom-up approach)
      • 16.2.1.2 Revenue share analysis of Roquette Freres
      • 16.2.1.3 MnM repository analysis
      • 16.2.1.4 Primary interviews
    • 16.2.2 INSIGHTS FROM PRIMARY EXPERTS
    • 16.2.3 SEGMENTAL MARKET SIZE ESTIMATION (TOP-DOWN APPROACH)
  • 16.3 MARKET GROWTH RATE PROJECTIONS
  • 16.4 DATA TRIANGULATION
  • 16.5 STUDY ASSUMPTIONS
  • 16.6 RESEARCH LIMITATIONS
  • 16.7 RISK ANALYSIS

17 APPENDIX

  • 17.1 DISCUSSION GUIDE
  • 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 17.3 CUSTOMIZATION OPTIONS
  • 17.4 RELATED REPORTS
  • 17.5 AUTHOR DETAILS
Show more
Product Code: PH 3047

List of Tables

  • TABLE 1 PHARMACEUTICAL EXCIPIENTS MARKET: INCLUSIONS AND EXCLUSIONS
  • TABLE 2 PHARMACEUTICAL EXCIPIENTS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
  • TABLE 3 IMPENDING AND ONGOING PATENT EXPIRY OF BLOCKBUSTER THERAPEUTICS, 2023-2035
  • TABLE 4 LIST OF MULTIFUNCTIONAL EXCIPIENTS
  • TABLE 5 ACTIVE PHARMACEUTICAL INGREDIENTS (API) MERCHANT MARKET, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 6 PHARMACEUTICAL EXCIPIENTS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 7 HEALTH EXPENDITURE AND FINANCING, 2015-2024 (IN PERCENTAGE OF GDP)
  • TABLE 8 PHARMACEUTICAL EXCIPIENTS MARKET: ROLE IN ECOSYSTEM
  • TABLE 9 INDICATIVE PRICING ANALYSIS OF PRODUCT TYPES, BY KEY PLAYER, 2025 (USD/KG)
  • TABLE 10 INDICATIVE PRICING ANALYSIS OF EXCIPIENTS, BY REGION, 2025 (USD/KG)
  • TABLE 11 IMPORT DATA FOR HS CODE 290545 (GLYCEROL), 2021-2025 (USD)
  • TABLE 12 IMPORT DATA FOR HS CODE 290545 (GLYCEROL), 2021-2025 (TONS)
  • TABLE 13 EXPORT DATA FOR HS CODE 290545 (GLYCEROL), 2021-2025 (USD)
  • TABLE 14 EXPORT DATA FOR HS CODE 290545 (GLYCEROL), 2021-2025 (TONS)
  • TABLE 15 IMPORT DATA FOR HS CODE 350510 (DEXTRINS AND OTHER MODIFIED STARCHES, E.G. PREGELATINIZED OR ESTERIFIED STARCHES), 2021-2025 (USD)
  • TABLE 16 IMPORT DATA FOR HS CODE 350510 (DEXTRINS AND OTHER MODIFIED STARCHES, E.G. PREGELATINIZED OR ESTERIFIED STARCHES), 2021-2025 (TONS)
  • TABLE 17 EXPORT DATA FOR HS CODE 350510 (DEXTRINS AND OTHER MODIFIED STARCHES, E.G. PREGELATINIZED OR ESTERIFIED STARCHES), 2021-2025 (USD)
  • TABLE 18 EXPORT DATA FOR HS CODE 350510 (DEXTRINS AND OTHER MODIFIED STARCHES, E.G. PREGELATINIZED OR ESTERIFIED STARCHES), 2021-2025 (TONS)
  • TABLE 19 IMPORT DATA FOR HS CODE 290532 (PROPYLENE GLYCOL "PROPANE-1,2-DIOL), 2021-2025 (USD)
  • TABLE 20 IMPORT DATA FOR HS CODE 290532 (PROPYLENE GLYCOL "PROPANE-1,2-DIOL), 2021-2025 (TONS)
  • TABLE 21 EXPORT DATA FOR HS CODE 290532 (PROPYLENE GLYCOL/PROPANE-1,2-DIOL), 2021-2025 (USD)
  • TABLE 22 EXPORT DATA FOR HS CODE 290532 (PROPYLENE GLYCOL/PROPANE-1,2-DIOL), 2021-2025 (TONS)
  • TABLE 23 IMPORT DATA FOR HS CODE 283650 (CALCIUM CARBONATE), 2021-2025 (USD)
  • TABLE 24 IMPORT DATA FOR HS CODE 283650 (CALCIUM CARBONATE), 2021-2025 (TONS)
  • TABLE 25 EXPORT DATA FOR HS CODE 283650 (CALCIUM CARBONATE), 2021-2025 (USD)
  • TABLE 26 EXPORT DATA FOR HS CODE 283650 (CALCIUM CARBONATE), 2021-2025 (TONS)
  • TABLE 27 IMPORT DATA FOR HS CODE 250100 (SALTS, INCL. TABLE SALT AND DENATURED SALT, AND PURE SODIUM CHLORIDE), 2021-2025 (USD)
  • TABLE 28 IMPORT DATA FOR HS CODE 250100 (SALTS, INCL. TABLE SALT AND DENATURED SALT, AND PURE SODIUM CHLORIDE), 2021-2025 (TONS)
  • TABLE 29 EXPORT DATA FOR HS CODE 250100 (SALTS, INCL. TABLE SALT AND DENATURED SALT, AND PURE SODIUM CHLORIDE), 2021-2025 (USD)
  • TABLE 30 EXPORT DATA FOR HS CODE 250100 (SALTS, INCL. TABLE SALT AND DENATURED SALT, AND PURE SODIUM CHLORIDE), 2021-2025 (TONS)
  • TABLE 31 IMPORT DATA FOR HS CODE 290543 (MANNITOL), 2021-2025 (USD)
  • TABLE 32 IMPORT DATA FOR HS CODE 290543 (MANNITOL), 2021-2025 (USD)
  • TABLE 33 EXPORT DATA FOR HS CODE 290543 (MANNITOL), 2021-2025 (USD)
  • TABLE 34 EXPORT DATA FOR HS CODE 290543 (MANNITOL), 2021-2025 (TONS)
  • TABLE 35 IMPORT DATA FOR HS CODE: 3912 (CELLULOSE AND ITS CHEMICAL DERIVATIVES, N.E.S., IN PRIMARY FORMS), 2021-2025 (USD)
  • TABLE 36 IMPORT DATA FOR HS CODE: 3912 (CELLULOSE AND ITS CHEMICAL DERIVATIVES, N.E.S., IN PRIMARY FORMS), 2021-2025 (TONS)
  • TABLE 37 EXPORT DATA FOR HS CODE: 3912 (CELLULOSE AND ITS CHEMICAL DERIVATIVES, N.E.S., IN PRIMARY FORMS), 2021-2025 (USD)
  • TABLE 38 EXPORT DATA FOR HS CODE: 3912 (CELLULOSE AND ITS CHEMICAL DERIVATIVES, N.E.S., IN PRIMARY FORMS), 2021-2025 (TONS)
  • TABLE 39 PHARMACEUTICAL EXCIPIENTS MARKET: KEY CONFERENCES & EVENTS, 2026-2027
  • TABLE 40 US ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 41 IMPACT ANALYSIS ON END-USE INDUSTRIES
  • TABLE 42 PHARMACEUTICAL EXCIPIENTS MARKET: TECHNOLOGY/PRODUCT ROADMAP
  • TABLE 43 DETAILED ANALYSIS OF KEY PATENTS IN PHARMACEUTICAL EXCIPIENTS MARKET
  • TABLE 44 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 45 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 46 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 47 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 48 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 49 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT (%)
  • TABLE 50 KEY BUYING CRITERIA, BY END USER
  • TABLE 51 PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023-2031 (USD MILLION)
  • TABLE 52 PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 53 PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 54 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 55 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 56 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 57 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 58 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 59 PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 60 PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 61 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 62 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 63 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 64 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 65 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 66 PHARMACEUTICAL EXCIPIENTS MARKET FOR FATTY ALCOHOLS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 67 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR FATTY ALCOHOLS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 68 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR FATTY ALCOHOLS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 69 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR FATTY ALCOHOLS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 70 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR FATTY ALCOHOLS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 71 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR FATTY ALCOHOLS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 72 PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL STEARATES, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 73 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL STEARATES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 74 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL STEARATES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 75 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL STEARATES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 76 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL STEARATES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 77 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL STEARATES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 78 PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCERIN, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 79 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCERIN, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 80 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCERIN, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 81 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCERIN, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 82 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCERIN, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 83 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCERIN, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 84 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER OLEOCHEMICALS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 85 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER OLEOCHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 86 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER OLEOCHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 87 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER OLEOCHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 88 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER OLEOCHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 89 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER OLEOCHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 90 PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 91 PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 92 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 93 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 94 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 95 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 96 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 97 PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 98 PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 99 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 100 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 101 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 102 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 103 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 104 PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 105 PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 106 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 107 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 108 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 109 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 110 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 111 PHARMACEUTICAL EXCIPIENTS MARKET FOR LACTOSE, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 112 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR LACTOSE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 113 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR LACTOSE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 114 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR LACTOSE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 115 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR LACTOSE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 116 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR LACTOSE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 117 PHARMACEUTICAL EXCIPIENTS MARKET FOR SUCROSE, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 118 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUCROSE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 119 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUCROSE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 120 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUCROSE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 121 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUCROSE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 122 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUCROSE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 123 PHARMACEUTICAL EXCIPIENTS MARKET FOR DEXTROSE (D-GLUCOSE), BY REGION, 2023-2031 (USD MILLION)
  • TABLE 124 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR DEXTROSE (D-GLUCOSE), BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 125 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR DEXTROSE (D-GLUCOSE), BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 126 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR DEXTROSE (D-GLUCOSE), BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 127 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR DEXTROSE (D-GLUCOSE), BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 128 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR DEXTROSE (D-GLUCOSE), BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 129 PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 130 PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 131 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 132 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 133 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 134 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 135 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 136 PHARMACEUTICAL EXCIPIENTS MARKET FOR SORBITOL, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 137 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SORBITOL, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 138 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SORBITOL, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 139 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SORBITOL, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 140 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SORBITOL, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 141 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR SORBITOL, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 142 PHARMACEUTICAL EXCIPIENTS MARKET FOR MANNITOL, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 143 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MANNITOL, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 144 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MANNITOL, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 145 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR MANNITOL, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 146 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MANNITOL, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 147 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR MANNITOL, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 148 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER SUGAR ALCOHOLS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 149 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER SUGAR ALCOHOLS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 150 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER SUGAR ALCOHOLS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 151 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER SUGAR ALCOHOLS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 152 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER SUGAR ALCOHOLS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 153 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER SUGAR ALCOHOLS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 154 PHARMACEUTICAL EXCIPIENTS MARKET FOR ARTIFICIAL SWEETENERS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 155 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ARTIFICIAL SWEETENERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 156 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ARTIFICIAL SWEETENERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 157 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ARTIFICIAL SWEETENERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 158 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ARTIFICIAL SWEETENERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 159 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR ARTIFICIAL SWEETENERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 160 PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 161 PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 162 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 163 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 164 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 165 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 166 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 167 PHARMACEUTICAL EXCIPIENTS MARKET FOR MICROCRYSTALLINE CELLULOSE, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 168 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MICROCRYSTALLINE CELLULOSE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 169 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MICROCRYSTALLINE CELLULOSE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 170 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR MICROCRYSTALLINE CELLULOSE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 171 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MICROCRYSTALLINE CELLULOSE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 172 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR MICROCRYSTALLINE CELLULOSE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 173 PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ETHERS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 174 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ETHERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 175 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ETHERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 176 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ETHERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 177 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ETHERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 178 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ETHERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 179 PHARMACEUTICAL EXCIPIENTS MARKET FOR CMC & CROSCARMELLOSE SODIUM, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 180 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CMC & CROSCARMELLOSE SODIUM, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 181 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CMC & CROSCARMELLOSE SODIUM, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 182 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CMC & CROSCARMELLOSE SODIUM, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 183 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CMC & CROSCARMELLOSE SODIUM, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 184 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CMC & CROSCARMELLOSE SODIUM, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 185 PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ESTERS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 186 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ESTERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 187 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ESTERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 188 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ESTERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 189 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ESTERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 190 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ESTERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 191 PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 192 PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 193 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 194 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 195 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 196 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 197 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 198 PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED STARCH, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 199 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED STARCH, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 200 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED STARCH, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 201 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED STARCH, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 202 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED STARCH, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 203 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED STARCH, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 204 PHARMACEUTICAL EXCIPIENTS MARKET FOR DRIED STARCH, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 205 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR DRIED STARCH, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 206 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR DRIED STARCH, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 207 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR DRIED STARCH, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 208 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR DRIED STARCH, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 209 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR DRIED STARCH, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 210 PHARMACEUTICAL EXCIPIENTS MARKET FOR CONVERTED STARCH, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 211 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CONVERTED STARCH, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 212 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CONVERTED STARCH, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 213 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CONVERTED STARCH, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 214 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CONVERTED STARCH, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 215 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CONVERTED STARCH, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 216 PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 217 PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 218 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 219 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 220 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 221 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 222 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 223 PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 224 PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 225 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 226 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 227 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 228 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 229 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 230 PHARMACEUTICAL EXCIPIENTS MARKET FOR POLYETHYLENE GLYCOL (PEG), BY REGION, 2023-2031 (USD MILLION)
  • TABLE 231 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR POLYETHYLENE GLYCOL (PEG), BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 232 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR POLYETHYLENE GLYCOL (PEG), BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 233 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR POLYETHYLENE GLYCOL (PEG), BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 234 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR POLYETHYLENE GLYCOL (PEG), BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 235 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR POLYETHYLENE GLYCOL (PEG), BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 236 PHARMACEUTICAL EXCIPIENTS MARKET FOR PROPYLENE GLYCOL (PG), BY REGION, 2023-2031 (USD MILLION)
  • TABLE 237 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PROPYLENE GLYCOL (PG), BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 238 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR PROPYLENE GLYCOL (PG), BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 239 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR PROPYLENE GLYCOL (PG), BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 240 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PROPYLENE GLYCOL (PG), BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 241 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR PROPYLENE GLYCOL (PG), BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 242 PHARMACEUTICAL EXCIPIENTS MARKET FOR POVIDONES, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 243 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR POVIDONES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 244 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR POVIDONES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 245 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR POVIDONES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 246 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR POVIDONES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 247 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR POVIDONES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 248 PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 249 PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 250 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 251 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 252 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 253 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 254 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 255 PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROLATUM, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 256 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROLATUM, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 257 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROLATUM, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 258 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROLATUM, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 259 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROLATUM, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 260 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROLATUM, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 261 PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL WAXES, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 262 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL WAXES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 263 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL WAXES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 264 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL WAXES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 265 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL WAXES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 266 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL WAXES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 267 PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL OILS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 268 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL OILS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 269 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL OILS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 270 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL OILS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 271 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL OILS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 272 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL OILS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 273 PHARMACEUTICAL EXCIPIENTS MARKET FOR ACRYLIC POLYMERS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 274 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACRYLIC POLYMERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 275 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACRYLIC POLYMERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 276 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACRYLIC POLYMERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 277 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACRYLIC POLYMERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 278 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACRYLIC POLYMERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 279 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER PETROCHEMICAL EXCIPIENTS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 280 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER PETROCHEMICAL EXCIPIENTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 281 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER PETROCHEMICAL EXCIPIENTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 282 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER PETROCHEMICAL EXCIPIENTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 283 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER PETROCHEMICAL EXCIPIENTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 284 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER PETROCHEMICAL EXCIPIENTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 285 PHARMACEUTICAL EXCIPIENTS MARKET FOR PROTEINS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 286 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PROTEINS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 287 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR PROTEINS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 288 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR PROTEINS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 289 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PROTEINS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 290 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR PROTEINS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 291 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORGANIC CHEMICALS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 292 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORGANIC CHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 293 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORGANIC CHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 294 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORGANIC CHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 295 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORGANIC CHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 296 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORGANIC CHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 297 PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 298 PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 299 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 300 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 301 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 302 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 303 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 304 PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM PHOSPHATE, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 305 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM PHOSPHATE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 306 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM PHOSPHATE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 307 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM PHOSPHATE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 308 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM PHOSPHATE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 309 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM PHOSPHATE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 310 PHARMACEUTICAL EXCIPIENTS MARKET FOR METAL OXIDES, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 311 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR METAL OXIDES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 312 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR METAL OXIDES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 313 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR METAL OXIDES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 314 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR METAL OXIDES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 315 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR METAL OXIDES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 316 PHARMACEUTICAL EXCIPIENTS MARKET FOR HALITES, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 317 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR HALITES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 318 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR HALITES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 319 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR HALITES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 320 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR HALITES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 321 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR HALITES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 322 PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM CARBONATE, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 323 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM CARBONATE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 324 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM CARBONATE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 325 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM CARBONATE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 326 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM CARBONATE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 327 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM CARBONATE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 328 PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM SULFATE, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 329 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM SULFATE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 330 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM SULFATE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 331 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM SULFATE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 332 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM SULFATE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 333 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM SULFATE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 334 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER INORGANIC CHEMICALS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 335 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER INORGANIC CHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 336 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER INORGANIC CHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 337 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER INORGANIC CHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 338 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER INORGANIC CHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 339 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER INORGANIC CHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 340 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 341 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 342 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 343 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 344 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 345 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 346 PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023-2031 (USD MILLION)
  • TABLE 347 PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 348 PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 349 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 350 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 351 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 352 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 353 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 354 TYPICAL COMPOSITION OF TABLETS
  • TABLE 355 PHARMACEUTICAL EXCIPIENTS MARKET FOR TABLETS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 356 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR TABLETS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 357 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR TABLETS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 358 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR TABLETS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 359 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR TABLETS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 360 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR TABLETS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 361 PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 362 PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 363 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 364 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 365 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 366 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 367 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 368 PHARMACEUTICAL EXCIPIENTS MARKET FOR HARD-GELATIN CAPSULES, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 369 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR HARD-GELATIN CAPSULES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 370 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR HARD-GELATIN CAPSULES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 371 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR HARD-GELATIN CAPSULES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 372 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR HARD-GELATIN CAPSULES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 373 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR HARD-GELATIN CAPSULES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 374 PHARMACEUTICAL EXCIPIENTS MARKET FOR SOFT-GELATIN CAPSULES, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 375 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOFT-GELATIN CAPSULES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 376 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOFT-GELATIN CAPSULES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 377 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOFT-GELATIN CAPSULES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 378 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOFT-GELATIN CAPSULES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 379 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOFT-GELATIN CAPSULES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 380 PHARMACEUTICAL EXCIPIENTS MARKET FOR LIQUID FORMULATIONS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 381 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR LIQUID FORMULATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 382 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR LIQUID FORMULATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 383 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR LIQUID FORMULATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 384 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR LIQUID FORMULATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 385 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR LIQUID FORMULATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 386 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORAL FORMULATIONS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 387 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORAL FORMULATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 388 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORAL FORMULATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 389 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORAL FORMULATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 390 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORAL FORMULATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 391 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORAL FORMULATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 392 PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 393 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 394 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 395 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 396 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 397 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 398 TYPICAL COMPOSITION OF PARENTERAL FORMULATIONS
  • TABLE 399 EXCIPIENTS USED IN PARENTERAL FORMULATIONS
  • TABLE 400 PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 401 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 402 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 403 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 404 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 405 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 406 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 407 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 408 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 409 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 410 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 411 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 412 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2031 (USD MILLION)
  • TABLE 413 PHARMACEUTICAL EXCIPIENTS MARKET FOR FILLERS & DILUENTS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 414 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR FILLERS & DILUENTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 415 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR FILLERS & DILUENTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 416 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR FILLERS & DILUENTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 417 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR FILLERS & DILUENTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 418 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR FILLERS & DILUENTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 419 PHARMACEUTICAL EXCIPIENTS MARKET FOR SUSPENDING & VISCOSITY AGENTS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 420 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUSPENDING & VISCOSITY AGENTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 421 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUSPENDING & VISCOSITY AGENTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 422 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUSPENDING & VISCOSITY AGENTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 423 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUSPENDING & VISCOSITY AGENTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 424 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUSPENDING & VISCOSITY AGENTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 425 PHARMACEUTICAL EXCIPIENTS MARKET FOR COATING AGENTS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 426 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR COATING AGENTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 427 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR COATING AGENTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 428 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR COATING AGENTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 429 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR COATING AGENTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 430 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR COATING AGENTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 431 PHARMACEUTICAL EXCIPIENTS MARKET FOR BINDERS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 432 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR BINDERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 433 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR BINDERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 434 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR BINDERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 435 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR BINDERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 436 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR BINDERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 437 PHARMACEUTICAL EXCIPIENTS MARKET FOR FLAVORING AGENTS & SWEETENERS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 438 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR FLAVORING AGENTS & SWEETENERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 439 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR FLAVORING AGENTS & SWEETENERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 440 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR FLAVORING AGENTS & SWEETENERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 441 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR FLAVORING AGENTS & SWEETENERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 442 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR FLAVORING AGENTS & SWEETENERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 443 PHARMACEUTICAL EXCIPIENTS MARKET FOR DISINTEGRANTS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 444 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR DISINTEGRANTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 445 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR DISINTEGRANTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 446 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR DISINTEGRANTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 447 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR DISINTEGRANTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 448 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR DISINTEGRANTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 449 PHARMACEUTICAL EXCIPIENTS MARKET FOR COLORANTS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 450 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR COLORANTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 451 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR COLORANTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 452 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR COLORANTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 453 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR COLORANTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 454 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR COLORANTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 455 PHARMACEUTICAL EXCIPIENTS MARKET FOR LUBRICANTS & GLIDANTS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 456 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR LUBRICANTS & GLIDANTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 457 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR LUBRICANTS & GLIDANTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 458 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR LUBRICANTS & GLIDANTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 459 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR LUBRICANTS & GLIDANTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 460 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR LUBRICANTS & GLIDANTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 461 PHARMACEUTICAL EXCIPIENTS MARKET FOR PRESERVATIVES, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 462 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PRESERVATIVES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 463 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR PRESERVATIVES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 464 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR PRESERVATIVES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 465 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PRESERVATIVES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 466 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR PRESERVATIVES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 467 PHARMACEUTICAL EXCIPIENTS MARKET FOR EMULSIFYING AGENTS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 468 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR EMULSIFYING AGENTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 469 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR EMULSIFYING AGENTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 470 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR EMULSIFYING AGENTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 471 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR EMULSIFYING AGENTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 472 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR EMULSIFYING AGENTS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 473 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 474 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 475 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 476 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 477 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 478 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 479 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023-2031 (USD MILLION)
  • TABLE 480 PHARMACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 481 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 482 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 483 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 484 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 485 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 486 PHARMACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 487 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 488 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 489 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 490 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 491 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 492 PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED-RELEASE, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 493 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED-RELEASE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 494 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED-RELEASE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 495 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED-RELEASE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 496 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED-RELEASE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 497 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED-RELEASE, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 498 PHARMACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY ENHANCEMENT, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 499 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY ENHANCEMENT, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 500 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY ENHANCEMENT, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 501 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY ENHANCEMENT, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 502 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY ENHANCEMENT, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 503 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY ENHANCEMENT, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 504 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITY APPLICATIONS, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 505 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITY APPLICATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 506 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITY APPLICATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 507 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITY APPLICATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 508 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITY APPLICATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 509 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITY APPLICATIONS, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 510 PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 511 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 512 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023-2031 (USD MILLION)
  • TABLE 513 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 514 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 515 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 516 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 517 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 518 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 519 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 520 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 521 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 522 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 523 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 524 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 525 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2031 (USD MILLION)
  • TABLE 526 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023-2031 (USD MILLION)
  • TABLE 527 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 528 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 529 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023-2031 (USD MILLION)
  • TABLE 530 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023-2031 (USD MILLION)
  • TABLE 531 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 532 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 533 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 534 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 535 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 536 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 537 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 538 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 539 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 540 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 541 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 542 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 543 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2031 (USD MILLION)
  • TABLE 544 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023-2031 (USD MILLION)
  • TABLE 545 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 546 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 547 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023-2031 (USD MILLION)
  • TABLE 548 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023-2031 (USD MILLION)
  • TABLE 549 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 550 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 551 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 552 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 553 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 554 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 555 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 556 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 557 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 558 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 559 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 560 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 561 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2031 (USD MILLION)
  • TABLE 562 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023-2031 (USD MILLION)
  • TABLE 563 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 564 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 565 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023-2031 (USD MILLION)
  • TABLE 566 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023-2031 (USD MILLION)
  • TABLE 567 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 568 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 569 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 570 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 571 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 572 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 573 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 574 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 575 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 576 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 577 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 578 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 579 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2031 (USD MILLION)
  • TABLE 580 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023-2031 (USD MILLION)
  • TABLE 581 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 582 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 583 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023-2031 (USD MILLION)
  • TABLE 584 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023-2031 (USD MILLION)
  • TABLE 585 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 586 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 587 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 588 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 589 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 590 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 591 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 592 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 593 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 594 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 595 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 596 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 597 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2031 (USD MILLION)
  • TABLE 598 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023-2031 (USD MILLION)
  • TABLE 599 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 600 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 601 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023-2031 (USD MILLION)
  • TABLE 602 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023-2031 (USD MILLION)
  • TABLE 603 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 604 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 605 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 606 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 607 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 608 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 609 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 610 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 611 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 612 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 613 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 614 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 615 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2031 (USD MILLION)
  • TABLE 616 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023-2031 (USD MILLION)
  • TABLE 617 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 618 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 619 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023-2031 (USD MILLION)
  • TABLE 620 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023-2031 (USD MILLION)
  • TABLE 621 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 622 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 623 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 624 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 625 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 626 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 627 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 628 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 629 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 630 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 631 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 632 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 633 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2031 (USD MILLION)
  • TABLE 634 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023-2031 (USD MILLION)
  • TABLE 635 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 636 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 637 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023-2031 (USD MILLION)
  • TABLE 638 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 639 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023-2031 (USD MILLION)
  • TABLE 640 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 641 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 642 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 643 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 644 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 645 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 646 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 647 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 648 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 649 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 650 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 651 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 652 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2031 (USD MILLION)
  • TABLE 653 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023-2031 (USD MILLION)
  • TABLE 654 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 655 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 656 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023-2031 (USD MILLION)
  • TABLE 657 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023-2031 (USD MILLION)
  • TABLE 658 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 659 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 660 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 661 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 662 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 663 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 664 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 665 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 666 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 667 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 668 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 669 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 670 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2031 (USD MILLION)
  • TABLE 671 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023-2031 (USD MILLION)
  • TABLE 672 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 673 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 674 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023-2031 (USD MILLION)
  • TABLE 675 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023-2031 (USD MILLION)
  • TABLE 676 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 677 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 678 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 679 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 680 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 681 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 682 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 683 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 684 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 685 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 686 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 687 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 688 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2031 (USD MILLION)
  • TABLE 689 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023-2031 (USD MILLION)
  • TABLE 690 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 691 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 692 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023-2031 (USD MILLION)
  • TABLE 693 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 694 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023-2031 (USD MILLION)
  • TABLE 695 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 696 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 697 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 698 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 699 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 700 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 701 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 702 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 703 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 704 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 705 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 706 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 707 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2031 (USD MILLION)
  • TABLE 708 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023-2031 (USD MILLION)
  • TABLE 709 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 710 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 711 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023-2031 (USD MILLION)
  • TABLE 712 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023-2031 (USD MILLION)
  • TABLE 713 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 714 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 715 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 716 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 717 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 718 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 719 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 720 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 721 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 722 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 723 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 724 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 725 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2031 (USD MILLION)
  • TABLE 726 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023-2031 (USD MILLION)
  • TABLE 727 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 728 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 729 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023-2031 (USD MILLION)
  • TABLE 730 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023-2031 (USD MILLION)
  • TABLE 731 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 732 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 733 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 734 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 735 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 736 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 737 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 738 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 739 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 740 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 741 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 742 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 743 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2031 (USD MILLION)
  • TABLE 744 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023-2031 (USD MILLION)
  • TABLE 745 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 746 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 747 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023-2031 (USD MILLION)
  • TABLE 748 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023-2031 (USD MILLION)
  • TABLE 749 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 750 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 751 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 752 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 753 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 754 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 755 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 756 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 757 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 758 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 759 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 760 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 761 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2031 (USD MILLION)
  • TABLE 762 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023-2031 (USD MILLION)
  • TABLE 763 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 764 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 765 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023-2031 (USD MILLION)
  • TABLE 766 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023-2031 (USD MILLION)
  • TABLE 767 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 768 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 769 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 770 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 771 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 772 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 773 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 774 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 775 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 776 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 777 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 778 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 779 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2031 (USD MILLION)
  • TABLE 780 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023-2031 (USD MILLION)
  • TABLE 781 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 782 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 783 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023-2031 (USD MILLION)
  • TABLE 784 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023-2031 (USD MILLION)
  • TABLE 785 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 786 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 787 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 788 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 789 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 790 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 791 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 792 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 793 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 794 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 795 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 796 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 797 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2031 (USD MILLION)
  • TABLE 798 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023-2031 (USD MILLION)
  • TABLE 799 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 800 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 801 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023-2031 (USD MILLION)
  • TABLE 802 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
  • TABLE 803 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023-2031 (USD MILLION)
  • TABLE 804 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 805 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 806 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 807 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 808 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 809 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 810 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 811 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 812 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 813 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 814 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 815 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 816 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2031 (USD MILLION)
  • TABLE 817 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023-2031 (USD MILLION)
  • TABLE 818 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 819 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 820 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023-2031 (USD MILLION)
  • TABLE 821 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023-2031 (USD MILLION)
  • TABLE 822 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 823 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 824 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 825 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 826 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 827 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 828 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 829 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 830 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 831 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 832 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 833 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 834 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2031 (USD MILLION)
  • TABLE 835 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023-2031 (USD MILLION)
  • TABLE 836 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 837 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 838 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023-2031 (USD MILLION)
  • TABLE 839 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023-2031 (USD MILLION)
  • TABLE 840 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 841 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 842 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 843 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 844 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 845 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 846 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 847 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 848 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 849 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 850 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 851 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 852 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2031 (USD MILLION)
  • TABLE 853 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023-2031 (USD MILLION)
  • TABLE 854 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 855 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 856 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023-2031 (USD MILLION)
  • TABLE 857 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023-2031 (USD MILLION)
  • TABLE 858 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 859 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 860 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 861 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 862 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 863 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 864 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 865 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 866 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 867 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 868 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 869 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 870 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2031 (USD MILLION)
  • TABLE 871 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023-2031 (USD MILLION)
  • TABLE 872 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 873 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 874 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023-2031 (USD MILLION)
  • TABLE 875 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023-2031 (USD MILLION)
  • TABLE 876 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023-2031 (USD MILLION)
  • TABLE 877 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 878 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 879 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 880 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 881 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 882 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 883 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 884 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 885 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 886 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 887 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 888 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 889 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2031 (USD MILLION)
  • TABLE 890 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023-2031 (USD MILLION)
  • TABLE 891 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 892 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 893 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023-2031 (USD MILLION)
  • TABLE 894 GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023-2031 (USD MILLION)
  • TABLE 895 GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 896 GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 897 GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 898 GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 899 GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 900 GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 901 GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 902 GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 903 GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 904 GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 905 GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 906 GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 907 GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2031 (USD MILLION)
  • TABLE 908 GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023-2031 (USD MILLION)
  • TABLE 909 GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 910 GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 911 GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023-2031 (USD MILLION)
  • TABLE 912 REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023-2031 (USD MILLION)
  • TABLE 913 REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 914 REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 915 REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 916 REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 917 REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 918 REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 919 REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 920 REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 921 REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 922 REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 923 REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 924 REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 925 REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2031 (USD MILLION)
  • TABLE 926 REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023-2031 (USD MILLION)
  • TABLE 927 REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 928 REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 929 REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023-2031 (USD MILLION)
  • TABLE 930 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023-2031 (USD MILLION)
  • TABLE 931 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 932 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 933 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 934 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 935 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 936 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 937 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 938 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 939 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 940 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 941 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 942 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 943 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2031 (USD MILLION)
  • TABLE 944 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023-2031 (USD MILLION)
  • TABLE 945 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 946 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023-2031 (USD MILLION)
  • TABLE 947 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023-2031 (USD MILLION)
  • TABLE 948 OVERVIEW OF MAJOR STRATEGIES DEPLOYED BY KEY PLAYERS IN THE PHARMACEUTICAL EXCIPIENTS MARKET, 2023-2026
  • TABLE 949 PHARMACEUTICAL EXCIPIENTS MARKET: DEGREE OF COMPETITION
  • TABLE 950 PHARMACEUTICAL EXCIPIENTS MARKET: REGION FOOTPRINT
  • TABLE 951 PHARMACEUTICAL EXCIPIENTS MARKET: PRODUCT FOOTPRINT
  • TABLE 952 PHARMACEUTICAL EXCIPIENTS MARKET: FUNCTIONALITY FOOTPRINT
  • TABLE 953 PHARMACEUTICAL EXCIPIENTS MARKET: FUNCTIONALITY APPLICATION FOOTPRINT
  • TABLE 954 PHARMACEUTICAL EXCIPIENTS MARKET: LIST OF KEY STARTUPS/SMES
  • TABLE 955 PHARMACEUTICAL EXCIPIENTS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2025
  • TABLE 956 PHARMACEUTICAL EXCIPIENTS MARKET: PRODUCT APPROVALS & LAUNCHES, JANUARY 2023-SEPTEMBER 2026
  • TABLE 957 PHARMACEUTICAL EXCIPIENTS MARKET: DEALS, JANUARY 2023-SEPTEMBER 2026
  • TABLE 958 PHARMACEUTICAL EXCIPIENTS MARKET: EXPANSIONS, JANUARY 2023-SEPTEMBER 2026
  • TABLE 959 ROQUETTE FRERES: COMPANY OVERVIEW
  • TABLE 960 ROQUETTE FRERES: PRODUCTS OFFERED
  • TABLE 961 ROQUETTE FRERES: PRODUCT LAUNCHES, JANUARY 2023-SEPTEMBER 2026
  • TABLE 962 ROQUETTE FRERES: DEALS, JANUARY 2023-SEPTEMBER 2026
  • TABLE 963 ARCHER-DANIELS-MIDLAND COMPANY: COMPANY OVERVIEW
  • TABLE 964 ARCHER-DANIELS-MIDLAND COMPANY: PRODUCTS OFFERED
  • TABLE 965 ARCHER-DANIELS-MIDLAND COMPANY: DEALS, JANUARY 2023-SEPTEMBER 2026
  • TABLE 966 BASF SE: COMPANY OVERVIEW
  • TABLE 967 BASF SE: PRODUCTS OFFERED
  • TABLE 968 BASF SE: DEALS, JANUARY 2023-SEPTEMBER 2026
  • TABLE 969 BASF SE: EXPANSIONS, JANUARY 2023-SEPTEMBER 2026
  • TABLE 970 EVONIK INDUSTRIES AG: COMPANY OVERVIEW
  • TABLE 971 EVONIK INDUSTRIES AG: PRODUCTS OFFERED
  • TABLE 972 EVONIK INDUSTRIES AG: EXPANSIONS, JANUARY 2023-SEPTEMBER 2026
  • TABLE 973 ASHLAND INC.: COMPANY OVERVIEW
  • TABLE 974 ASHLAND INC.: PRODUCTS OFFERED
  • TABLE 975 ASHLAND INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023-SEPTEMBER 2026
  • TABLE 976 KERRY GROUP PLC: COMPANY OVERVIEW
  • TABLE 977 KERRY GROUP PLC: PRODUCTS OFFERED
  • TABLE 978 KERRY GROUP PLC: DEALS, JANUARY 2023-SEPTEMBER 2026
  • TABLE 979 MERCK: COMPANY OVERVIEW
  • TABLE 980 MERCK KGAA: PRODUCTS OFFERED
  • TABLE 981 MERCK KGAA: DEALS, JANUARY 2023- SEPTEMBER 2026
  • TABLE 982 ASSOCIATED BRITISH FOODS PLC: COMPANY OVERVIEW
  • TABLE 983 ASSOCIATED BRITISH FOODS PLC: PRODUCTS OFFERED
  • TABLE 984 ASSOCIATED BRITISH FOODS PLC: DEALS, JANUARY 2023- SEPTEMBER 2026
  • TABLE 985 WACKER CHEMIE AG: COMPANY OVERVIEW
  • TABLE 986 WACKER CHEMIE AG: PRODUCTS OFFERED
  • TABLE 987 AIR LIQUIDE S.A.: COMPANY OVERVIEW
  • TABLE 988 AIR LIQUIDE S.A.: PRODUCTS OFFERED
  • TABLE 989 AIR LIQUIDE S.A.: PRODUCT LAUNCHES, JANUARY 2023- SEPTEMBER 2026
  • TABLE 990 DOW INC.: COMPANY OVERVIEW
  • TABLE 991 DOW INC.: PRODUCTS OFFERED
  • TABLE 992 BERKSHIRE HATHAWAY INC.: COMPANY OVERVIEW
  • TABLE 993 BERKSHIRE HATHAWAY INC.: PRODUCTS OFFERED
  • TABLE 994 COLORCON, INC.: COMPANY OVERVIEW
  • TABLE 995 COLORCON, INC.: PRODUCTS OFFERED
  • TABLE 996 COLORCON, INC.: PRODUCT LAUNCHES, JANUARY 2023- SEPTEMBER 2026
  • TABLE 997 COLORCON, INC.: DEALS, JANUARY 2023- SEPTEMBER 2026
  • TABLE 998 COLORCON, INC.: EXPANSIONS, JANUARY 2023- SEPTEMBER 2026
  • TABLE 999 DFE PHARMA GMBH & CO. KG: COMPANY OVERVIEW
  • TABLE 1000 DFE PHARMA GMBH & CO. KG: PRODUCTS OFFERED
  • TABLE 1001 ACTYLIS: COMPANY OVERVIEW
  • TABLE 1002 ACTYLIS: PRODUCTS OFFERED
  • TABLE 1003 ACTYLIS: DEALS, JANUARY 2023-SEPTEMBER 2026
  • TABLE 1004 CRODA INTERNATIONAL PLC: COMPANY OVERVIEW
  • TABLE 1005 CRODA INTERNATIONAL PLC: PRODUCTS OFFERED
  • TABLE 1006 CRODA INTERNATIONAL PLC: DEALS, JANUARY 2023- SEPTEMBER 2026
  • TABLE 1007 CRODA INTERNATIONAL PLC: EXPANSIONS, JANUARY 2023-SEPTEMBER 2026
  • TABLE 1008 GATTEFOSSE SAS: COMPANY OVERVIEW
  • TABLE 1009 GATTEFOSSE SAS: PRODUCTS OFFERED
  • TABLE 1010 J. RETTENMAIER & SOHNE GMBH + CO KG: COMPANY OVERVIEW
  • TABLE 1011 J. RETTENMAIER & SOHNE GMBH + CO KG: PRODUCTS OFFERED
  • TABLE 1012 SHIN-ETSU CHEMICAL CO., LTD.: COMPANY OVERVIEW
  • TABLE 1013 SHIN-ETSU CHEMICAL CO., LTD.: PRODUCTS OFFERED
  • TABLE 1014 SHIN-ETSU CHEMICAL CO., LTD.: DEALS, JANUARY 2023-SEPTEMBER 2026
  • TABLE 1015 SHIN-ETSU CHEMICAL CO., LTD.: EXPANSIONS, JANUARY 2023-SEPTEMBER 2026
  • TABLE 1016 INNOPHOS HOLDINGS, INC.: COMPANY OVERVIEW
  • TABLE 1017 MEGGLE GMBH & CO. KG: COMPANY OVERVIEW
  • TABLE 1018 FUJI CHEMICAL INDUSTRIES CO., LTD.: COMPANY OVERVIEW
  • TABLE 1019 COREL PHARMA CHEM PVT. LTD.: COMPANY OVERVIEW
  • TABLE 1020 BIOGRUND GMBH: COMPANY OVERVIEW
  • TABLE 1021 NITIKA PHARMACEUTICAL SPECIALTIES PVT. LTD.: COMPANY OVERVIEW
  • TABLE 1022 R.T. VANDERBILT HOLDING COMPANY, INC.: COMPANY OVERVIEW
  • TABLE 1023 BENEO GMBH: COMPANY OVERVIEW
  • TABLE 1024 SIGACHI INDUSTRIES LIMITED: COMPANY OVERVIEW
  • TABLE 1025 JH NANHANG LIFE SCIENCES CO., LTD.: COMPANY OVERVIEW
  • TABLE 1026 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
  • TABLE 1027 PHARMACEUTICAL EXCIPIENTS MARKET: RISK ANALYSIS

List of Figures

  • FIGURE 1 PHARMACEUTICAL EXCIPIENTS MARKET: SEGMENTS CONSIDERED
  • FIGURE 2 REGIONAL SCOPE
  • FIGURE 3 PHARMACEUTICAL EXCIPIENTS MARKET: YEARS CONSIDERED
  • FIGURE 4 MARKET SCENARIO
  • FIGURE 5 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, 2024-2031
  • FIGURE 6 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL EXCIPIENTS MARKET, 2023-2025
  • FIGURE 7 DISRUPTIONS INFLUENCING GROWTH OF PHARMACEUTICAL EXCIPIENTS MARKET
  • FIGURE 8 HIGH-GROWTH SEGMENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, 2026-2031
  • FIGURE 9 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN PHARMACEUTICAL EXCIPIENTS, IN TERMS OF VALUE, DURING FORECAST PERIOD
  • FIGURE 10 INCREASING SIZE OF CLINICAL DEVELOPMENT PIPELINE TO PROPEL MARKET GROWTH
  • FIGURE 11 US AND ORAL FORMULATIONS SEGMENT COMMANDED LARGEST MARKET SHARES IN 2025
  • FIGURE 12 GERMANY TO REGISTER HIGHER CAGR DURING FORECAST PERIOD
  • FIGURE 13 PHARMACEUTICAL EXCIPIENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 14 GLOBAL PHARMACEUTICAL R&D SPEND, 2018-2028
  • FIGURE 15 PHARMACEUTICAL EXCIPIENTS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 16 PHARMACEUTICAL EXCIPIENTS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 17 PHARMACEUTICAL EXCIPIENTS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 18 PHARMACEUTICAL EXCIPIENTS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 19 INDICATIVE PRICING ANALYSIS, BY PRODUCT TYPE, 2025 (USD/KG)
  • FIGURE 20 INDICATIVE PRICING ANALYSIS OF PRODUCT TYPES, BY REGION, 2025 (USD/KG)
  • FIGURE 21 PHARMACEUTICAL EXCIPIENTS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 22 VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE
  • FIGURE 23 TOP APPLICANTS/OWNERS (COMPANIES) FOR PHARMACEUTICAL EXCIPIENTS PATENTS, 2015-2025
  • FIGURE 24 PHARMACEUTICAL EXCIPIENTS MARKET: AI USE CASES
  • FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT
  • FIGURE 26 KEY BUYING CRITERIA, BY END USER
  • FIGURE 27 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET SNAPSHOT
  • FIGURE 28 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET SNAPSHOT
  • FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS, 2023-2025 (USD MILLION)
  • FIGURE 30 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
  • FIGURE 31 PHARMACEUTICAL EXCIPIENTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
  • FIGURE 32 PHARMACEUTICAL EXCIPIENTS MARKET: COMPANY FOOTPRINT
  • FIGURE 33 PHARMACEUTICAL EXCIPIENTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
  • FIGURE 34 EV/EBITDA OF KEY VENDORS
  • FIGURE 35 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 36 PHARMACEUTICAL EXCIPIENTS MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 37 ROQUETTE FRERES: COMPANY SNAPSHOT (2025)
  • FIGURE 38 ARCHER-DANIELS-MIDLAND COMPANY: COMPANY SNAPSHOT (2025)
  • FIGURE 39 BASF SE: COMPANY SNAPSHOT (2025)
  • FIGURE 40 EVONIK INDUSTRIES AG: COMPANY SNAPSHOT (2025)
  • FIGURE 41 ASHLAND INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 42 KERRY GROUP PLC: COMPANY SNAPSHOT (2025)
  • FIGURE 43 MERCK KGAA: COMPANY SNAPSHOT (2025)
  • FIGURE 44 ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT (2025)
  • FIGURE 45 WACKER CHEMIE AG: COMPANY SNAPSHOT (2025)
  • FIGURE 46 AIR LIQUIDE S.A.: COMPANY SNAPSHOT (2025)
  • FIGURE 47 DOW INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 48 BERKSHIRE HATHAWAY INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 49 CRODA INTERNATIONAL PLC: COMPANY SNAPSHOT (2025)
  • FIGURE 50 SHIN-ETSU CHEMICAL CO., LTD.: COMPANY SNAPSHOT (2025)
  • FIGURE 51 PHARMACEUTICAL EXCIPIENTS MARKET: RESEARCH DESIGN
  • FIGURE 52 PHARMACEUTICAL EXCIPIENTS MARKET: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 53 PHARMACEUTICAL EXCIPIENTS MARKET: BREAKDOWN OF PRIMARY INTERVIEWS
  • FIGURE 54 PHARMACEUTICAL EXCIPIENTS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2025
  • FIGURE 55 COMPANY REVENUE ANALYSIS-BASED ESTIMATION: BOTTOM-UP APPROACH (2025)
  • FIGURE 56 REVENUE SHARE ANALYSIS OF ROQUETTE FRERES (FRANCE) (2025)
  • FIGURE 57 PHARMACEUTICAL EXCIPIENTS MARKET SIZE VALIDATION FROM PRIMARY SOURCES
  • FIGURE 58 PHARMACEUTICAL EXCIPIENTS MARKET: TOP-DOWN APPROACH
  • FIGURE 59 PHARMACEUTICAL EXCIPIENTS MARKET: CAGR PROJECTIONS
  • FIGURE 60 PHARMACEUTICAL EXCIPIENTS MARKET: DATA TRIANGULATION
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!